JPMORGAN CHASE & CO - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,907,495
-28.1%
6,910,882
+12.7%
0.00%
-33.3%
Q2 2023$30,487,943
+22.8%
6,134,395
+22.1%
0.00%0.0%
Q1 2023$24,821,000
+104563.7%
5,024,544
+33.3%
0.00%0.0%
Q4 2022$23,715
-99.9%
3,770,283
-4.9%
0.00%
-50.0%
Q3 2022$42,830,000
-16.6%
3,965,620
-11.9%
0.01%
-14.3%
Q2 2022$51,335,000
+58.4%
4,502,994
+26.6%
0.01%
+75.0%
Q1 2022$32,406,000
-40.1%
3,557,117
-1.8%
0.00%
-33.3%
Q4 2021$54,059,000
-36.7%
3,623,279
+9.1%
0.01%
-45.5%
Q3 2021$85,370,000
+31.7%
3,321,800
+33.7%
0.01%
+37.5%
Q2 2021$64,802,000
-22.9%
2,484,735
+4.3%
0.01%
-27.3%
Q1 2021$84,080,000
+70.2%
2,381,867
+21.7%
0.01%
+57.1%
Q4 2020$49,397,000
-22.4%
1,957,089
+15.9%
0.01%
-36.4%
Q3 2020$63,669,000
+5.4%
1,687,916
+19.7%
0.01%
-8.3%
Q2 2020$60,395,000
+700.8%
1,410,446
+263.5%
0.01%
+500.0%
Q1 2020$7,542,000
+244.7%
387,984
+360.6%
0.00%
Q4 2019$2,188,000
+528.7%
84,237
+560.3%
0.00%
Q3 2019$348,000
+22.1%
12,758
+19.3%
0.00%
Q2 2019$285,000
+82.7%
10,695
+98.3%
0.00%
Q1 2019$156,000
+5.4%
5,392
-2.0%
0.00%
Q4 2018$148,0005,5040.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders